Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-Line Long-Term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial

Samir S. Taneja

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Pages (from-to)1124-1125
    Number of pages2
    JournalThe Journal of urology
    Volume196
    Issue number4
    DOIs
    StatePublished - Oct 1 2016

    ASJC Scopus subject areas

    • Urology

    Cite this